AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Sunitinib-induced thrombotic microangiopathy: a case report
  • +2
  • Mohammadreza ardalan,
  • Amirreza Khalaji,
  • Sepideh Zonuni Vahed,
  • Mohammadreza Moslemi,
  • Alireza Mirghaffari
Mohammadreza ardalan
Tabriz University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Amirreza Khalaji
Tabriz University of Medical Sciences
Author Profile
Sepideh Zonuni Vahed
Tabriz University of Medical Sciences
Author Profile
Mohammadreza Moslemi
Tabriz University of Medical Sciences Faculty of Medicine
Author Profile
Alireza Mirghaffari
Tabriz University of Medical Sciences
Author Profile

Abstract

Sunitinib-induced thrombotic microangiopathy (TMA) is a secondary TMA caused by Sunitinib.Despite the extensive use of the drug ,little is known about this complication of Sunitinib. In this study, we reported a 63 years old male with Sunitinib induced TMA treated for metastatic renal cell carcinoma.